ELFN1 Activators
ELFN1 Activators refers to a specific class of chemical compounds designed to modulate the activity of the extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1 (ELFN1). ELFN1 is a cell adhesion molecule primarily expressed in the central nervous system, where it plays a crucial role in synaptic communication. The activation of ELFN1 is associated with the modulation of synaptic plasticity, a phenomenon vital for learning and memory processes in the brain. The chemical class of ELFN1 activators is characterized by its ability to enhance the function of ELFN1, promoting its interactions with other synaptic proteins and facilitating the fine-tuning of neuronal communication.
Structurally, ELFN1 activators often possess unique molecular features that enable them to bind specifically to ELFN1, triggering conformational changes or facilitating protein-protein interactions that result in increased ELFN1 activity. These compounds are designed to act as molecular switches, modulating the signaling pathways associated with synaptic transmission. By targeting ELFN1, these activators have the potential to influence synaptic strength and connectivity, offering a novel approach to understanding and manipulating neural circuitry. Research in this chemical class is ongoing, with scientists exploring the intricate mechanisms underlying ELFN1 activation and its implications for synaptic function. The development of ELFN1 activators holds promise for unraveling the complexities of neural communication and may contribute to advancements in our understanding of fundamental processes within the central nervous system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which can enhance protein kinase A (PKA) activity. PKA could then phosphorylate proteins that interact with ELFN1, leading to its enhanced functional activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase-4 (PDE4), preventing the breakdown of cAMP. Elevated cAMP levels can activate PKA, which may indirectly enhance the activity of ELFN1 by phosphorylating associated regulatory proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. This can activate calcium-dependent kinases, potentially influencing proteins that modulate ELFN1’s activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may phosphorylate substrates that interact with ELFN1, potentially enhancing its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to modulate numerous signaling pathways, including those involving calcium signaling. Altered calcium dynamics can affect the activity of calcium-dependent proteins interacting with ELFN1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that changes the downstream AKT signaling. This alteration can indirectly influence proteins that are part of the ELFN1 signaling cascade. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene interferes with ryanodine receptors, altering calcium release from the endoplasmic reticulum, potentially impacting calcium-dependent processes associated with ELFN1 activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a CaMKII inhibitor, which impacts calcium/calmodulin-dependent processes. This could influence proteins that interact with ELFN1, affecting its activity. | ||||||
Benzamil•HCl | 161804-20-2 | sc-201070 | 50 mg | $195.00 | 1 | |
Benzamil is an ENaC inhibitor, altering sodium ion flux. Changes in ion homeostasis can influence signaling pathways associated with ELFN1 activity. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is a myosin light chain kinase inhibitor, affecting cytoskeletal dynamics. This may indirectly affect the localization or function of ELFN1-associated proteins. | ||||||